iTonic Holdings Ltd (ITOC)
About iTonic Holdings Ltd
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $523.0K
- Net income
- -$5.1M
- Total assets
- $9.1M
- Market cap
- $4.5M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $4.5M
- Shares outstanding
- 18.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 5, 2024
iTonic Holdings Ltd (ITOC) Stock Price
- Reported a net loss of $5.1M in FY2025.
- Trading 57% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review iTonic Holdings Ltd.
Write a review
News about iTonic Holdings Ltd
News & sentiment via Polygon.io
iTonic Holdings Ltd: frequently asked questions
Is iTonic Holdings Ltd an American company?
iTonic Holdings Ltd is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is iTonic Holdings Ltd publicly traded?
Yes — iTonic Holdings Ltd is a publicly traded company. Its stock trades under the ticker symbol ITOC on the NASDAQ.
What does iTonic Holdings Ltd do?
iTonic Holdings Ltd is an American Medical Devices company in the Health & Beauty sector.
